Seeing Is Believing

Currently out of the existing stock ratings of Michael Yee, 376 are a BUY (80%), 93 are a HOLD (19.79%), 1 are a SELL (0.21%).
Analyst Michael Yee, currently employed at UBS, carries an average stock price target met ratio of 59.89% that have a potential upside of 31.02% achieved within 279 days. Previously, Michael Yee worked at JEFFERIES.
Michael Yee’s has documented 929 price targets and ratings displayed on 56 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 04-Nov-2026.
Analyst best performing recommendations are on IMRX (IMMUNEERING CORP).
The best stock recommendation documented was for IMRX (IMMUNEERING CORP) at 6/25/2025. The price target of $3.5 was fulfilled within 2 days with a profit of $0.48 (15.89%) receiving and performance score of 79.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
5 years 4 months 26 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
5 years 9 months 30 days ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
6 years 6 months 6 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
6 years 6 months 6 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
7 years 22 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
Which stock is Michael Yee most bullish on?
Which stock is Michael Yee most reserved on?
What Year was the first public recommendation made by Michael Yee?